Adalta Ltd has released a press release.
GE Healthcare collaboration advances to next stage
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from AdAlta
- AdAlta granted Japanese patent for AD-214
- Mutiple Dose Part Of Ad-214 Phase I Trial Commenced
- Investor briefing-AD-214 top line single dose safety results
- Appendix 4D and Interim Financial Report
- FDA Orphan Drug Designation for AD-214
Later from AdAlta
- R&D Tax Incentive Facility
- AdAlta secures AD-214 resupply
- AD-214 pathway to IPF efficacy studies
- Webinar and presentation on AD-214 strategy
- CAR-T collaboration with Carina Biotech
Follow AdAlta into a list and get an email when it puts out news.
Follow AdAlta